C07D 251/72
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D251/72 (Condensed with carbocyclic rings or ring systems) appears on 8 US grants and 11 published applications in this corpus.
Search patents in C07D- Granted patents
- 8
- Published applications
- 11
- Assignees
- 8
- Inventors
- 20
- Latest grant
- 29 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Glass structure29 Jun 2021US 11,048,112 B2Sekisui Chemical Co., Ltd.
- 5-HT2B antagonists19 Dec 2017US 9,845,298 B1National Institute of Biological Sciences, Beijing
- 5-HT2B antagonists5 Sep 2017US 9,751,845 B2National Institute of Biological Sciences, Beijing
- Preparation and use of compounds as aspartyl protease inhibitors7 Feb 2012US 8,110,682 B2Schering Corporation
- Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses3 Aug 2010US 7,767,676 B2Merck Sante
- Non-peptide targeted therapeutics and uses thereof12 Dec 2024US 2024/0408247 A1Crinetics Pharmaceuticals, Inc.
- Non-peptide targeted therapeutics and uses thereof29 Aug 2024US 2024/0285628 A1Crinetics Pharmaceuticals, Inc.
- Glass structure17 Sep 2020US 2020/0292858 A1Sekisui Chemical Co., Ltd.
- 5-HT2B Antagonists26 Apr 2018US 2018/0111908 A1National Institute of Biological Sciences, Beijing
- 5-HT2B Antagonists7 Dec 2017US 2017/0349559 A1National Institute of Biological Sciences, Beijing
Most cited
By later US patents
- Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses14US 7,034,021 B2Lipha · 2006
- Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses9US 7,452,883 B2Merck Sante · 2008
- Insecticidal 4,6-diamino-1,2-dihydro-1,3,5-triazine derivatives7US 5,300,503 AFMC Corporation · 1994
- Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses7US 7,767,676 B2Merck Sante · 2010